Hakan Paydak
Concepts (217)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 22 | 2022 | 197 | 5.430 |
Why?
| Defibrillators, Implantable | 8 | 2019 | 64 | 2.910 |
Why?
| Anti-Arrhythmia Agents | 8 | 2020 | 87 | 2.440 |
Why?
| Electrocardiography | 9 | 2021 | 290 | 2.320 |
Why?
| Catheter Ablation | 8 | 2018 | 131 | 2.050 |
Why?
| Arrhythmias, Cardiac | 5 | 2020 | 98 | 1.950 |
Why?
| Tachycardia, Supraventricular | 3 | 2021 | 39 | 1.890 |
Why?
| Hospitalization | 7 | 2022 | 705 | 1.630 |
Why?
| Tachycardia | 3 | 2021 | 32 | 1.300 |
Why?
| Amiodarone | 3 | 2017 | 23 | 1.170 |
Why?
| Pacemaker, Artificial | 3 | 2019 | 39 | 0.990 |
Why?
| Heart Rate | 3 | 2021 | 357 | 0.970 |
Why?
| Vena Cava, Superior | 2 | 2015 | 24 | 0.940 |
Why?
| Anticoagulants | 5 | 2019 | 270 | 0.860 |
Why?
| Tachycardia, Ventricular | 4 | 2020 | 43 | 0.810 |
Why?
| Humans | 54 | 2023 | 54246 | 0.800 |
Why?
| Cardiomyopathy, Dilated | 1 | 2020 | 41 | 0.750 |
Why?
| Echocardiography, Transesophageal | 1 | 2020 | 73 | 0.740 |
Why?
| Hospital Mortality | 5 | 2017 | 465 | 0.730 |
Why?
| Middle Aged | 20 | 2020 | 13070 | 0.690 |
Why?
| Metoprolol | 1 | 2019 | 13 | 0.680 |
Why?
| Warfarin | 3 | 2019 | 87 | 0.680 |
Why?
| Syncope | 2 | 2013 | 30 | 0.660 |
Why?
| Bundle-Branch Block | 2 | 2012 | 11 | 0.650 |
Why?
| Heparin | 2 | 2016 | 97 | 0.630 |
Why?
| Male | 29 | 2022 | 27312 | 0.620 |
Why?
| Heart Failure | 3 | 2019 | 541 | 0.610 |
Why?
| Lung Diseases, Interstitial | 1 | 2017 | 22 | 0.600 |
Why?
| Hemothorax | 1 | 2016 | 5 | 0.590 |
Why?
| Length of Stay | 4 | 2015 | 683 | 0.590 |
Why?
| Heart Conduction System | 2 | 2015 | 25 | 0.580 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 35 | 0.580 |
Why?
| Treatment Outcome | 13 | 2022 | 5604 | 0.580 |
Why?
| Cost of Illness | 2 | 2015 | 132 | 0.570 |
Why?
| Prosthesis Implantation | 1 | 2016 | 47 | 0.570 |
Why?
| Wolff-Parkinson-White Syndrome | 1 | 2016 | 7 | 0.560 |
Why?
| Torsades de Pointes | 3 | 2014 | 15 | 0.560 |
Why?
| Pneumonia | 1 | 2017 | 129 | 0.550 |
Why?
| Propafenone | 1 | 2015 | 2 | 0.540 |
Why?
| Tachycardia, Ectopic Atrial | 1 | 2015 | 3 | 0.540 |
Why?
| Flecainide | 1 | 2015 | 5 | 0.540 |
Why?
| Accessory Atrioventricular Bundle | 1 | 2014 | 3 | 0.520 |
Why?
| Mucolipidoses | 1 | 2014 | 4 | 0.510 |
Why?
| Propofol | 1 | 2015 | 28 | 0.510 |
Why?
| Postoperative Hemorrhage | 1 | 2015 | 53 | 0.510 |
Why?
| Ventricular Dysfunction, Left | 2 | 2015 | 98 | 0.510 |
Why?
| Hospital Costs | 1 | 2015 | 84 | 0.500 |
Why?
| Exercise Test | 1 | 2015 | 151 | 0.500 |
Why?
| Electric Countershock | 4 | 2022 | 33 | 0.500 |
Why?
| Heart Ventricles | 3 | 2015 | 271 | 0.500 |
Why?
| Hyponatremia | 1 | 2013 | 15 | 0.470 |
Why?
| Female | 23 | 2022 | 28418 | 0.470 |
Why?
| Takotsubo Cardiomyopathy | 1 | 2013 | 25 | 0.460 |
Why?
| Theophylline | 1 | 2013 | 24 | 0.460 |
Why?
| Patient Safety | 1 | 2014 | 121 | 0.460 |
Why?
| Therapy, Computer-Assisted | 1 | 2013 | 34 | 0.450 |
Why?
| Health Care Costs | 1 | 2014 | 171 | 0.450 |
Why?
| Vascular Malformations | 1 | 2015 | 101 | 0.450 |
Why?
| Seasons | 1 | 2013 | 98 | 0.440 |
Why?
| Electrodes, Implanted | 1 | 2012 | 29 | 0.440 |
Why?
| Coronary Sinus | 1 | 2012 | 4 | 0.430 |
Why?
| Azygos Vein | 1 | 2012 | 12 | 0.430 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 10 | 0.430 |
Why?
| Heart Block | 2 | 2009 | 25 | 0.430 |
Why?
| Superior Vena Cava Syndrome | 1 | 2012 | 12 | 0.430 |
Why?
| Foreign-Body Migration | 1 | 2012 | 28 | 0.430 |
Why?
| Cardiac Pacing, Artificial | 1 | 2012 | 31 | 0.420 |
Why?
| Vena Cava, Inferior | 1 | 2012 | 78 | 0.420 |
Why?
| Catheters, Indwelling | 1 | 2012 | 68 | 0.410 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 38 | 0.410 |
Why?
| Heart Diseases | 1 | 2014 | 237 | 0.410 |
Why?
| Sinoatrial Node | 1 | 2011 | 3 | 0.400 |
Why?
| Adult | 15 | 2022 | 14182 | 0.390 |
Why?
| Catheterization, Central Venous | 1 | 2012 | 98 | 0.380 |
Why?
| Incidence | 4 | 2019 | 1082 | 0.360 |
Why?
| Retrospective Studies | 10 | 2023 | 6432 | 0.360 |
Why?
| Aged | 15 | 2022 | 10041 | 0.350 |
Why?
| Head and Neck Neoplasms | 1 | 2013 | 335 | 0.350 |
Why?
| Stroke | 3 | 2022 | 524 | 0.340 |
Why?
| Haloperidol | 1 | 2009 | 41 | 0.340 |
Why?
| Diagnosis, Differential | 5 | 2019 | 1136 | 0.340 |
Why?
| Magnetic Resonance Imaging | 2 | 2017 | 1604 | 0.320 |
Why?
| Aged, 80 and over | 7 | 2019 | 3429 | 0.300 |
Why?
| Postoperative Complications | 1 | 2014 | 1033 | 0.300 |
Why?
| Antipsychotic Agents | 1 | 2009 | 247 | 0.290 |
Why?
| Multiple Myeloma | 3 | 2017 | 3035 | 0.280 |
Why?
| Hypertension | 4 | 2019 | 563 | 0.270 |
Why?
| Risk Factors | 7 | 2019 | 3930 | 0.260 |
Why?
| Reproducibility of Results | 3 | 2015 | 1304 | 0.250 |
Why?
| Survival Rate | 2 | 2019 | 951 | 0.250 |
Why?
| Body Surface Potential Mapping | 1 | 2003 | 1 | 0.230 |
Why?
| Obesity | 1 | 2012 | 1197 | 0.230 |
Why?
| Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.230 |
Why?
| Databases, Factual | 6 | 2017 | 684 | 0.220 |
Why?
| Young Adult | 5 | 2017 | 4308 | 0.220 |
Why?
| Adolescent | 6 | 2017 | 6885 | 0.220 |
Why?
| Arkansas | 3 | 2019 | 2094 | 0.210 |
Why?
| Vagus Nerve Stimulation | 1 | 2022 | 11 | 0.210 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 150 | 0.200 |
Why?
| Follow-Up Studies | 2 | 2019 | 2387 | 0.200 |
Why?
| Disease Management | 2 | 2020 | 184 | 0.200 |
Why?
| Telemetry | 1 | 2021 | 36 | 0.200 |
Why?
| Time Factors | 6 | 2019 | 3212 | 0.200 |
Why?
| Sick Sinus Syndrome | 1 | 2019 | 2 | 0.180 |
Why?
| Hypoventilation | 1 | 2019 | 4 | 0.180 |
Why?
| Heart Arrest | 1 | 2022 | 159 | 0.180 |
Why?
| Sleep Apnea, Central | 1 | 2019 | 9 | 0.180 |
Why?
| Diaphragm | 1 | 2019 | 29 | 0.180 |
Why?
| Hyperlipidemias | 1 | 2019 | 51 | 0.180 |
Why?
| Recovery of Function | 1 | 2020 | 222 | 0.170 |
Why?
| Syndrome | 2 | 2015 | 252 | 0.170 |
Why?
| Antithrombins | 1 | 2019 | 21 | 0.170 |
Why?
| Artifacts | 1 | 2019 | 61 | 0.170 |
Why?
| Diabetes Complications | 1 | 2019 | 122 | 0.170 |
Why?
| Fatty Acids, Omega-3 | 1 | 2018 | 29 | 0.170 |
Why?
| Heart Injuries | 1 | 2018 | 20 | 0.170 |
Why?
| Death, Sudden, Cardiac | 1 | 2019 | 60 | 0.170 |
Why?
| Vascular System Injuries | 1 | 2018 | 37 | 0.160 |
Why?
| Adrenergic beta-Antagonists | 1 | 2019 | 105 | 0.160 |
Why?
| Cardiac Surgical Procedures | 1 | 2022 | 318 | 0.160 |
Why?
| Cardiotonic Agents | 1 | 2018 | 95 | 0.160 |
Why?
| United States | 5 | 2016 | 5200 | 0.160 |
Why?
| Cause of Death | 1 | 2019 | 165 | 0.160 |
Why?
| Seizures | 2 | 2022 | 208 | 0.160 |
Why?
| Ventricular Function, Left | 1 | 2019 | 181 | 0.150 |
Why?
| Hemorrhage | 2 | 2019 | 208 | 0.150 |
Why?
| Brain Ischemia | 1 | 2019 | 169 | 0.150 |
Why?
| Comorbidity | 3 | 2014 | 663 | 0.150 |
Why?
| Anti-Inflammatory Agents | 1 | 2018 | 175 | 0.150 |
Why?
| Prednisone | 1 | 2017 | 111 | 0.150 |
Why?
| Ventricular Fibrillation | 2 | 2009 | 17 | 0.150 |
Why?
| Accidents, Traffic | 1 | 2017 | 117 | 0.140 |
Why?
| Coronary Vessels | 1 | 2018 | 197 | 0.140 |
Why?
| Administration, Oral | 2 | 2019 | 459 | 0.140 |
Why?
| Maternal Exposure | 1 | 2017 | 87 | 0.140 |
Why?
| Perioperative Period | 1 | 2016 | 25 | 0.140 |
Why?
| Clinical Trials as Topic | 3 | 2018 | 490 | 0.140 |
Why?
| Radiography, Thoracic | 1 | 2016 | 69 | 0.140 |
Why?
| Odds Ratio | 2 | 2015 | 604 | 0.140 |
Why?
| Echocardiography | 2 | 2017 | 392 | 0.140 |
Why?
| Sex Factors | 2 | 2016 | 765 | 0.140 |
Why?
| Heart Atria | 2 | 2012 | 57 | 0.140 |
Why?
| Voltage-Gated Sodium Channel Blockers | 1 | 2015 | 8 | 0.130 |
Why?
| Ventricular Function | 1 | 2015 | 20 | 0.130 |
Why?
| Vitamin K | 1 | 2015 | 17 | 0.130 |
Why?
| Glucocorticoids | 1 | 2017 | 234 | 0.130 |
Why?
| Anesthetics, Intravenous | 1 | 2015 | 26 | 0.130 |
Why?
| Insurance, Health | 1 | 2016 | 132 | 0.130 |
Why?
| Age Factors | 2 | 2015 | 1195 | 0.130 |
Why?
| Forecasting | 1 | 2015 | 161 | 0.130 |
Why?
| Health Planning | 1 | 2014 | 14 | 0.130 |
Why?
| Thromboembolism | 1 | 2015 | 56 | 0.120 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2015 | 596 | 0.120 |
Why?
| Infusions, Intravenous | 1 | 2015 | 231 | 0.120 |
Why?
| Fatal Outcome | 1 | 2015 | 225 | 0.120 |
Why?
| Hematologic Neoplasms | 1 | 2015 | 99 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 291 | 0.120 |
Why?
| Cardiomyopathies | 1 | 2015 | 129 | 0.120 |
Why?
| Fibrinolytic Agents | 1 | 2015 | 139 | 0.120 |
Why?
| Methadone | 1 | 2014 | 169 | 0.120 |
Why?
| Radiography | 1 | 2015 | 524 | 0.120 |
Why?
| Ultrasonography | 2 | 2012 | 480 | 0.120 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2013 | 55 | 0.110 |
Why?
| Healthcare Disparities | 1 | 2016 | 268 | 0.110 |
Why?
| Vasodilator Agents | 1 | 2013 | 111 | 0.110 |
Why?
| Health Care Surveys | 1 | 2013 | 194 | 0.110 |
Why?
| Bradycardia | 1 | 2012 | 35 | 0.110 |
Why?
| After-Hours Care | 1 | 2012 | 11 | 0.110 |
Why?
| Angioplasty | 1 | 2012 | 26 | 0.110 |
Why?
| Cardiovascular Diseases | 1 | 2017 | 475 | 0.100 |
Why?
| Phlebography | 1 | 2012 | 70 | 0.100 |
Why?
| Prevalence | 1 | 2015 | 1022 | 0.100 |
Why?
| Angiography | 1 | 2012 | 147 | 0.100 |
Why?
| Mitral Valve | 1 | 2012 | 70 | 0.100 |
Why?
| Patient Admission | 1 | 2012 | 78 | 0.100 |
Why?
| Device Removal | 1 | 2012 | 97 | 0.100 |
Why?
| Subarachnoid Hemorrhage | 1 | 2012 | 65 | 0.100 |
Why?
| Disease Progression | 1 | 2014 | 913 | 0.100 |
Why?
| Stem Cell Transplantation | 1 | 2012 | 196 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2015 | 1084 | 0.100 |
Why?
| Hospitals | 2 | 2023 | 188 | 0.100 |
Why?
| Patient Discharge | 1 | 2013 | 353 | 0.100 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 573 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 923 | 0.090 |
Why?
| Dextrocardia | 1 | 2009 | 4 | 0.090 |
Why?
| Pregnancy | 1 | 2017 | 2620 | 0.090 |
Why?
| Algorithms | 1 | 2013 | 697 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2014 | 1679 | 0.080 |
Why?
| Inpatients | 2 | 2022 | 204 | 0.070 |
Why?
| Kidney Failure, Chronic | 1 | 2009 | 231 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2012 | 1213 | 0.070 |
Why?
| Cardiac Catheterization | 1 | 2009 | 258 | 0.070 |
Why?
| Magnetics | 1 | 2003 | 44 | 0.060 |
Why?
| Electrodes | 1 | 2022 | 39 | 0.050 |
Why?
| Vagus Nerve | 1 | 2022 | 27 | 0.050 |
Why?
| Animals | 2 | 2018 | 14385 | 0.050 |
Why?
| Logistic Models | 2 | 2012 | 990 | 0.040 |
Why?
| Drug Utilization | 1 | 2019 | 74 | 0.040 |
Why?
| Motor Vehicles | 1 | 2017 | 20 | 0.040 |
Why?
| Databases, Bibliographic | 1 | 2016 | 17 | 0.040 |
Why?
| Heparin, Low-Molecular-Weight | 1 | 2016 | 21 | 0.040 |
Why?
| Medically Uninsured | 1 | 2016 | 51 | 0.030 |
Why?
| Safety | 1 | 2015 | 92 | 0.030 |
Why?
| Heart | 1 | 2017 | 360 | 0.030 |
Why?
| Risk | 1 | 2015 | 343 | 0.030 |
Why?
| Age Distribution | 1 | 2013 | 198 | 0.030 |
Why?
| Systole | 1 | 2012 | 80 | 0.030 |
Why?
| Transplantation, Autologous | 1 | 2012 | 476 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2013 | 1048 | 0.020 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 367 | 0.020 |
Why?
| Child | 1 | 2003 | 7337 | 0.020 |
Why?
| Situs Inversus | 1 | 2009 | 4 | 0.020 |
Why?
| Kidney Diseases | 1 | 2012 | 293 | 0.020 |
Why?
| Prospective Studies | 1 | 2015 | 2604 | 0.020 |
Why?
| Risk Assessment | 1 | 2012 | 1361 | 0.020 |
Why?
| Coronary Angiography | 1 | 2009 | 411 | 0.020 |
Why?
| Kidney | 1 | 2012 | 820 | 0.020 |
Why?
|
|
Paydak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|